Aspen Appears Unfazed As Potential Difficulties Loom
Management Delivered A Defiant Results Call While The Street Remains Skeptical
Analysts posted wary notes about the prospects of South African pharmaceutical firm Aspen as its financial year came to an end, while management maintained confidence in the firm’s “solid results.”
